Assure Tech (Hangzhou) Co Ltd Class A 688075
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥34.87
- Day Range
- ¥35.14–36.66
- 52-Week Range
- ¥28.76–45.00
- Bid/Ask
- ¥36.09 / ¥36.16
- Market Cap
- ¥4.59 Bil
- Volume/Avg
- 1.1 Mil / 441,095
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 8.39
- Dividend Yield (Trailing)
- 1.11%
- Dividend Yield (Forward)
- 1.11%
- Total Yield
- 1.11%
Company Profile
Assure Tech (Hangzhou) Co Ltd is a biotechnology company. The company is engaged in research & development, production, sell of diagnostic reagents, POCT and biological materials.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 791
- Website
- http://www.diareagent.com
Comparables
Valuation
|
Metric
|
688075
|
688253
|
603392
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 19.62 | 85.49 |
Price/Book Value | 0.89 | 2.70 | 7.57 |
Price/Sales | 8.39 | 8.00 | 34.36 |
Price/Cash Flow | 37.53 | 15.34 | 402.76 |
Price/Earnings
688075
688253
603392
Financial Strength
|
Metric
|
688075
|
688253
|
603392
|
|---|---|---|---|
Quick Ratio | 4.69 | 15.40 | 3.81 |
Current Ratio | 9.37 | 15.84 | 4.48 |
Interest Coverage | 55.37 | 2,238.82 | −59.06 |
Quick Ratio
688075
688253
603392
Profitability
|
Metric
|
688075
|
688253
|
603392
|
|---|---|---|---|
Return on Assets (Normalized) | −0.47% | 12.17% | −3.06% |
Return on Equity (Normalized) | −0.54% | 13.13% | −3.76% |
Return on Invested Capital (Normalized) | −0.62% | 12.68% | −4.05% |
Return on Assets
688075
688253
603392
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Txplbzdg | Drpmr | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Xlxnkdgk | Zbrlsv | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Fchppbwgy | Mlthsk | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Hlhmbmgb | Yrqrtd | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Sdrldyqm | Djd | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Jdpvcrk | Zcvp | $28.1 Bil | |||
| Moderna Inc
MRNA
| Hxvgjtld | Fzqd | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Qtywbbqc | Llgs | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Wvbxfyfj | Qbggpn | $13.4 Bil | |||
| Incyte Corp
INCY
| Pshbmjvv | Mjfkb | $12.7 Bil |
United States